Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03657641
Title Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Southern California
Indications

colorectal cancer

Therapies

Pembrolizumab + Regorafenib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.